(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 4.99% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.08%.
Treace Medical Concepts's revenue in 2026 is $205,307,000.On average, 7 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,679,367,668, with the lowest TMCI revenue forecast at $13,014,714,546, and the highest TMCI revenue forecast at $14,135,259,877. On average, 7 Wall Street analysts forecast TMCI's revenue for 2027 to be $14,717,319,118, with the lowest TMCI revenue forecast at $13,766,513,967, and the highest TMCI revenue forecast at $15,842,416,867.
In 2028, TMCI is forecast to generate $15,757,871,950 in revenue, with the lowest revenue forecast at $14,403,852,577 and the highest revenue forecast at $17,010,437,421.